143 related articles for article (PubMed ID: 30004289)
1. ABO blood type and risk of hepatocellular carcinoma: a meta-analysis.
Liu F; Li C; Zhu J; Ren L; Qi X
Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):927-933. PubMed ID: 30004289
[TBL] [Abstract][Full Text] [Related]
2. Risk of hepatocellular carcinoma in relation to ABO blood type.
Iavarone M; Della Corte C; Pelucchi C; Marconi M; Trotti R; Triolo M; Manini MA; La Vecchia C
Dig Liver Dis; 2016 Jan; 48(1):94-6. PubMed ID: 26611335
[TBL] [Abstract][Full Text] [Related]
3. Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China.
Li X; Xu H; Ding Z; Jin Q; Gao P
Medicine (Baltimore); 2016 Dec; 95(49):e5587. PubMed ID: 27930575
[TBL] [Abstract][Full Text] [Related]
4. ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Yu CH; Yu JH; Liu L; Xie SS; Li WW; Yang X; Fan WB; Gai ZT; Chen SJ; Kato N
PLoS One; 2012; 7(1):e29928. PubMed ID: 22235351
[TBL] [Abstract][Full Text] [Related]
5. Association between ABO genotype and risk of hepatocellular carcinoma in Koreans.
Shim HJ; Lee R; Shin MH; Kim HN; Cho D; Ahn HR; Kweon SS
Asian Pac J Cancer Prev; 2015; 16(7):2771-5. PubMed ID: 25854361
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of ABO blood group and Rhesus factor in cirrhotic patients with hepatocellular carcinoma.
Oral A; Sahin T
Sci Rep; 2019 Dec; 9(1):19087. PubMed ID: 31836844
[TBL] [Abstract][Full Text] [Related]
7. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis accuracy of serum Glypican-3 level in patients with hepatocellular carcinoma and liver cirrhosis: a meta-analysis.
Liu JW; Zuo XL; Wang S
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3655-73. PubMed ID: 26502856
[TBL] [Abstract][Full Text] [Related]
9. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
Yuan JM; Gao YT; Ong CN; Ross RK; Yu MC
J Natl Cancer Inst; 2006 Apr; 98(7):482-90. PubMed ID: 16595784
[TBL] [Abstract][Full Text] [Related]
10. Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance.
Liu F; Wang XW; Chen L; Hu P; Ren H; Hu HD
Aliment Pharmacol Ther; 2016 Jun; 43(12):1253-61. PubMed ID: 27117732
[TBL] [Abstract][Full Text] [Related]
11. Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies.
Chen J; Han Y; Xu C; Xiao T; Wang B
Eur J Cancer Prev; 2015 Mar; 24(2):89-99. PubMed ID: 24809655
[TBL] [Abstract][Full Text] [Related]
12. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
13. Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan.
Chen CL; Yang WS; Yang HI; Chen CF; You SL; Wang LY; Lu SN; Liu CJ; Kao JH; Chen PJ; Chen DS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1659-71. PubMed ID: 24895413
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
15. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
16. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
[TBL] [Abstract][Full Text] [Related]
17. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
18. The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection.
Abu-Amara M; Cerocchi O; Malhi G; Sharma S; Yim C; Shah H; Wong DK; Janssen HL; Feld JJ
Gut; 2016 Aug; 65(8):1347-58. PubMed ID: 25934760
[TBL] [Abstract][Full Text] [Related]
19. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
20. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
